Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs

被引:135
|
作者
Potrc, Tanja [1 ]
Baumgartner, Sasa [1 ]
Roskar, Robert [1 ]
Planinsek, Odon [1 ]
Lavric, Zoran [1 ]
Kristl, Julijana [1 ]
Kocbek, Petra [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia
关键词
Electrospinning; Nanofibers; Polycaprolactone; Poorly soluble drugs; Oromucosal drug delivery; BIOPHARMACEUTICS CLASSIFICATION-SYSTEM; POLYMER NANOFIBERS; CONTROLLED-RELEASE; FIBERS; NANOPARTICLES; FORMULATION; FABRICATION; MEMBRANES; IBUPROFEN; MIXTURES;
D O I
10.1016/j.ejps.2015.04.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The number of poorly water-soluble drug candidates is rapidly increasing; this represents a major challenge for the pharmaceutical industry. As a consequence, novel formulation approaches are required. Furthermore, if such a drug candidate is intended for the therapy of a specific group of the population, such as geriatric or pediatric, the formulation challenge is even greater, with the need to produce a dosage form that is acceptable for specific patients. Therefore, the goal of our study was to explore electrospun polycaprolactone (PCL) nanofibers as a novel nanodelivery system adopted for the oromucosal administration of poorly water-soluble drugs. The nanofibers were evaluated in comparison with polymer films loaded with ibuprofen or carvedilol as the model drugs. Scanning electron microscopy revealed that the amount of incorporated drug affects the diameter and the morphology of the nanofibers. The average fiber diameter increased with a higher drug loading, whereas the morphology of the nanofibers was noticeably changed in the case of nanofibers with 50% and 60% ibuprofen. The incorporation of drugs into the electrospun PCL nanofibers was observed to reduce their crystallinity. Based on the morphology of the nanofibers and the films, and the differential scanning calorimetry results obtained in this study, it can be assumed that the drugs incorporated into the nanofibers were partially molecularly dispersed in the PCL matrix and partially in the form of dispersed nanocrystals. The incorporation of both model drugs into the PCL nanofibers significantly improved their dissolution rates. The PCL nanofibers released almost 100% of the incorporated ibuprofen in 4 h, whereas only up to 77% of the incorporated carvedilol was released during the same time period, indicating the influence of the drug's properties, such as molecular weight and solubility, on its release from the PCL matrix. The obtained results clearly demonstrated the advantages of the new nanodelivery system compared to the drug-loaded polymer films that were used as the reference formulation. As a result, electrospinning was shown to be a very promising nanotechnology-based approach to the formulation of poorly water-soluble drugs in order to enhance their dissolution. In addition, the great potential of the produced drug-loaded PCL nanofiber mats for subsequent formulation as oromucosal drug delivery systems for children and the elderly was confirmed. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:101 / 113
页数:13
相关论文
共 50 条
  • [31] Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs
    Bhakay, Anagha
    Azad, Mohammad
    Bilgili, Ecevit
    Dave, Rajesh
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 461 (1-2) : 367 - 379
  • [32] pH-sensitive core-shell electrospun nanofibers based on polyvinyl alcohol/polycaprolactone as a potential drug delivery system for the chemotherapy against cervical cancer
    Yan, Eryun
    Jiang, Jinyu
    Yang, Xiuying
    Fan, Liquan
    Wang, Yuwei
    An, Qinglong
    Zhang, Zuoyuan
    Lu, Borong
    Wang, Dianyu
    Zhang, Deqing
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 55
  • [33] Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers
    Canbolat, M. Fatih
    Celebioglu, Asli
    Uyar, Tamer
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2014, 115 : 15 - 21
  • [34] Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs
    He, Wei
    Lu, Yi
    Qi, Jianping
    Chen, Lingyun
    Hu, Fuqiang
    Wu, Wei
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 441 (1-2) : 269 - 278
  • [35] Solubility, the Main Concern for Poorly Water-soluble Drugs: Techniques and Alternatives
    Singh, Komal
    Singh, Preet Amol
    Frank, Amanda
    Arora, Saahil
    Sharma, Rajiv
    Bajwa, Neha
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (12) : 2248 - 2260
  • [36] Electrospun Nanofibers of Polycaprolactone/Collagen as a Sustained-Release Drug Delivery System for Artemisinin
    Huo, Peipei
    Han, Xinxu
    Zhang, Wenyu
    Zhang, Jing
    Kumar, Parveen
    Liu, Bo
    PHARMACEUTICS, 2021, 13 (08)
  • [37] Successfully tailoring the pore size of mesoporous silica nanoparticles: Exploitation of delivery systems for poorly water-soluble drugs
    Jia, Lejiao
    Shen, Jingyi
    Li, Zhenyu
    Zhang, Dianrui
    Zhang, Qiang
    Duan, Cunxian
    Liu, Guangpu
    Zheng, Dandan
    Liu, Yue
    Tian, Xiaona
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 439 (1-2) : 81 - 91
  • [38] Optimal delivery of poorly soluble drugs using electrospun nanofiber technology: Challenges, state of the art, and future directions
    Pattnaik, Satyanarayan
    Swain, Kalpana
    Ramakrishna, Seeram
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2023, 15 (02)
  • [39] Electrospun nanofibers of polyCD/PMAA polymers and their potential application as drug delivery system
    Oliveira, Michele F.
    Suarez, Diego
    Barbosa Rocha, Julio Cezar
    Novaes de Carvalho Teixeira, Alvaro Vianna
    Cortes, Maria E.
    De Sousa, Frederico B.
    Sinisterra, Ruben D.
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2015, 54 : 252 - 261
  • [40] Functionally Engineered Nanosized Particles in Pharmaceutics: Improved Oral Delivery of Poorly Water-soluble Drugs
    Ozeki, Tetsuya
    Tagami, Tatsuaki
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (35) : 6259 - 6269